Enterococcal infections: host response, therapeutic, and prophylactic possibilities (Q35710126)

9 August 2017

1 reference

title

Enterococcal infections: host response, therapeutic, and prophylactic possibilities (English)

1 reference

9 August 2017

Stefanie Koch

1

1 reference

9 August 2017

Markus Hufnagel

series ordinal

2

1 reference

9 August 2017

Christian Theilacker

series ordinal

3

1 reference

9 August 2017

Johannes Huebner

series ordinal

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

9 August 2017

1 reference

9 August 2017

22

1 reference

9 August 2017

822-830

1 reference

9 August 2017

7

1 reference

Nonhuman Reservoirs of Enterococci

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Vancomycin-resistant enterococcal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Carriage of group D streptococci in the human bowel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Enterococci at the crossroads of food safety?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

A double-blind, controlled trial of bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Virulence of enterococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Nosocomial infections in combined medical-surgical intensive care units in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Clinical and molecular epidemiology of enterococcal bacteremia in a pediatric teaching hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

The pathogenicity of enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

The epidemiology of enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Endocarditis at the millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Aggregation substance increases adherence and internalization, but not translocation, of Enterococcus faecalis through different intestinal epithelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Enterococcus faecalis aggregation substance promotes opsonin-independent binding to human neutrophils via a complement receptor type 3-mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Aggregation substance promotes adherence, phagocytosis, and intracellular survival of Enterococcus faecalis within human macrophages and suppresses respiratory burst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Pheromone-inducible conjugation in Enterococcus faecalis: interbacterial and host-parasite chemical communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

A plasmid-encoded surface protein on Enterococcus faecalis augments its internalization by cultured intestinal epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Inducible expression of Enterococcus faecalis aggregation substance surface protein facilitates bacterial internalization by cultured enterocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Genogrouping and incidence of virulence factors of Enterococcus faecalis in liver transplant patients differ from blood culture and fecal isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

In vitro adhesive properties and virulence factors of Enterococcusfaecalis strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Frequency of aggregation substance and cytolysin genes among enterococcal endocarditis isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Ace is a collagen-binding MSCRAMM from Enterococcus faecalis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Enterococcus faecalis adhesin, ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Identification of a family of streptococcal surface proteins with extremely repetitive structure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Bap, a Staphylococcus aureus surface protein involved in biofilm formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Variant esp gene in vancomycin-sensitive Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

A variant enterococcal surface protein Esp(fm) in Enterococcus faecium; distribution among food, commensal, medical, and environmental isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Evidence that the hemolysin/bacteriocin phenotype of Enterococcus faecalis subsp. zymogenes can be determined by plasmids in different incompatibility groups as well as by the chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Enterococcus faecalis cytolysin without effect on the intestinal growth of susceptible enterococci in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

A simple model host for identifying Gram-positive virulence factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Chemical synthesis and biological activity of the gelatinase biosynthesis-activating pheromone of Enterococcus faecalis and its analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Characterization of a class of nonformylated Enterococcus faecalis-derived neutrophil chemotactic peptides: the sex pheromones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Cytotoxic effect of hemolytic culture supernatant from Enterococcus faecalis on mouse polymorphonuclear neutrophils and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Identification of ABC transporters in vancomycin-resistant Enterococcus faecium as potential targets for antibody therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

The Escherichia coli ATP-binding cassette (ABC) proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Inventory, assembly and analysis of Bacillus subtilis ABC transport systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Identification of novel staphylococcal virulence genes by in vivo expression technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Macrolide resistance genes in Enterococcus spp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Evidence for the translocation of Enterococcus faecalis across the mouse intestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Relative contributions of host and microbial factors in bacterial translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Enterococcus spp. produces slime and survives in rat peritoneal macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Teichoic Acid and the Group Antigen of Group D Streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Group and Type-specific Polysaccharides of Group D Streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Type and group polysaccharides of group D streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

THE CELL WALLS OF GROUP D STREPTOCOCCI. I. THE IMMUNOCHEMISTRY OF THE TYPE 1 CARBOHYDRATE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

SEROLOGICAL TYPES OF STREPTOCOCCUS FAECALIS AND ITS VARIETIES AND THEIR CELL WALL TYPE ANTIGEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Proposal of a new scheme for the serological typing of Enterococcus faecalis strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Comparative distribution of the serotypes of Enterococcus faecalis isolated from the urine of patients with urinary tract infections and the feces of healthy persons as determined by the slide agglutination reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Vaccines against polysaccharide antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Effect of gastrointestinal bleeding and oral medications on acquisition of vancomycin-resistant Enterococcus faecium in hospitalized patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Frequent transmission of enterococcal strains between mechanically ventilated patients treated at an intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Passive immunity in prevention and treatment of infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Passive antibody therapies: progress and continuing challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

Cloning of an Enterococcus faecalis endocarditis antigen: homology with adhesins from some oral streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

A novel means of self-protection, unrelated to toxin activation, confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

An HlyB-type function is required for expression of the Enterococcus faecalis hemolysin/bacteriocin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

High incidence of hemolysin production by Enterococcus (Streptococcus) faecalis strains associated with human parenteral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Nucleotide sequence of the gelatinase gene (gelE) from Enterococcus faecalis subsp. liquefaciens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Enterococcus faecalis antigens in human infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Proposed mechanisms for the translocation of intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Roles of antibodies and complement in phagocytic killing of enterococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Survival of Enterococcus faecalis in mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.027

7 January 2021

10.1016/J.VACCINE.2003.11.027

Identifiers

DOI

1 reference

9 August 2017

1 reference